Skip to main content
Medacta's Anterior Hybrid Interbody Fusion Device wins FDA clearance
7/7/2017

Medacta International's MectaLIF Anterior Hybrid Interbody Fusion Device has been granted clearance by the FDA. The device, which will be added to the company's MectaLIF Cage product suite, is intended for restoring the native disc space height and lordosis, improving in situ stability and maintaining spinal balance in the long term.

Full Story: